Top

Published in:

01-03-2014 | Regenerative Biology and Medicine in Osteoporosis (EM Schwartz and RE Guldberg, Section Editors)

Pharmacologic Augmentation of Implant Fixation in Osteopenic Bone

Authors: R. D. Ross, J. L. Hamilton, B. M. Wilson, D. R. Sumner, A. S. Virdi

Published in: Current Osteoporosis Reports | Issue 1/2014

Abstract

Osteoporosis presents a challenge for successful implant fixation due to an impaired healing response. Preclinical studies have consistently reported reduced osseointegration capability in trabecular bone. Although clinical studies of implant success in dentistry have not found a negative effect due to osteoporosis, low bone mass is a significant risk factor for implant migration in orthopedics. Pharmacologic treatment options that limit bone resorption or upregulate formation have been studied preclinically. While, both treatment options improve implant fixation, direct comparisons to-date have found anti-catabolic more effective than anabolic treatments for establishing implant fixation, but combination approaches are better than either treatment alone. Clinically, anti-catabolic treatments, particularly bisphosphonates have been shown to increase the longevity of implants, while limited clinical evidence on the effects of anabolic treatment exists. Preclinical experiments are needed to determine the effects of osteoporosis and subsequent treatment on the long-term maintenance of fixation and recovery after bone loss.

Makinen TJ, Alm JJ, Laine H, Svedstrom E, Aro HT. The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007;40:1041–7.PubMed

2.•

Lingard EA, Mitchell SY, Francis RM, Rawlings D, Peaston R, Birrell FN. The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty. Age Ageing. 2010;39:234–9. This study demonstrates that high co-incidence of osteoporosis and osteoarthritis in patients undergoing joint replacement surgery. PubMed

Labuda A, Papaioannou A, Pritchard J, Kennedy C, DeBeer J, Adachi JD. Prevalence of osteoporosis in osteoarthritic patients undergoing total hip or total knee arthroplasty. Arch Phys Med Rehabil. 2008;89:2373–4.PubMed

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMed

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.PubMed

6.•

Mears SC. Management of severe osteoporosis in primary total hip arthroplasty. Current Translational Geriatrics and Experimental Gerontology Reports. 2013;2:99–104. The author provides an interesting clinical perspective on the concerns that osteopenia presents to orthopedic surgeons.

Tsolaki IN, Madianos PN, Vrotsos JA. Outcomes of dental implants in osteoporotic patients. A literature review. J Prosthodont. 2009;18:309–23.PubMed

Bando K, Nitta H, Matsubara M, Ishikawa I. Bone mineral density in periodontally healthy and edentulous postmenopausal women. Ann Periodontol. 1998;3:322–6.PubMed

Krejci CB. Osteoporosis and periodontal disease: is there a relationship? J West Soc Periodontol Periodontal Abstr. 1996;44:37–42.PubMed

10.

Parfitt AM. Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. Clin Obstet Gynecol. 1987;30:789–811.PubMed

11.

Seeman E. Invited Review: Pathogenesis of osteoporosis. J Appl Physiol. 2003;95:2142–51.PubMed

12.

Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand. 1981;52:155–70.PubMed

13.

Karrholm J, Herberts P, Hultmark P, Malchau H, Nivbrant B, Thanner J. Radiostereometry of hip prostheses. Review of methodology and clinical results. Clin Orthop Relat Res. 1997:94–110.

14.

Nieuwenhuijse MJ, Valstar ER, Kaptein BL, Nelissen RG. Good diagnostic performance of early migration as a predictor of late aseptic loosening of acetabular cups: results from ten years of follow-up with Roentgen stereophotogrammetric analysis (RSA). J Bone Joint Surg Am. 2012;94:874–80.PubMed

15.•

Pijls BG, Nieuwenhuijse MJ, Fiocco M, Plevier JW, Middeldorp S, Nelissen RG, et al. Early proximal migration of cups is associated with late revision in THA: a systematic review and meta-analysis of 26 RSA studies and 49 survival studies. Acta Orthop. 2012;83:583–91. A very interesting review in which the association between early cup migration and the rate of revision surgery is analyzed. PubMed

16.

Pijls BG, Valstar ER, Nouta KA, Plevier JW, Fiocco M, Middeldorp S, et al. Early migration of tibial components is associated with late revision: a systematic review and meta-analysis of 21,000 knee arthroplasties. Acta Orthop. 2012;83:614–24.PubMed

17.

Szmukler-Moncler S, Salama H, Reingewirtz Y, Dubruille JH. Timing of loading and effect of micromotion on bone-dental implant interface: review of experimental literature. J Biomed Mater Res A. 1998;43:192–203.

18.

Kubo T, Shiga T, Hashimoto J, Yoshioka M, Honjo H, Urabe M, et al. Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet. J Ster Biochemis Molec Biol. 1999;68:197–202.

19.

Namkung-Matthai H, Appleyard R, Jansen J, Hao LJ, Maastricht S, Swain M, et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone. 2001;28:80–6.PubMed

20.

Davies JE. Mechanisms of endosseous integration. Int J Prosthodon. 1998;11:391–401.

21.

Mavrogenis AF, Dimitriou R, Parvizi J, Babis GC. Biology of implant osseointegration. J Musculoskelet Neuronal Interact. 2009;9:61–71.PubMed

22.•

Marco F, Milena F, Gianluca G, Vittoria O. Peri-implant osteogenesis in health and osteoporosis. Micron. 2005;36:630–44. This review gives a very nice summary of how osteoporosis affects the healing response to implant placement. PubMed

23.

Sumner DR, Virdi AS. Materials in hip surgery: bioactive coatings for implant fixation. In: Berry DJ, Lieberman JR, editors. Surgery of the hip. New York: Elsevier; 2013. p. 145–56.

24.

Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Rev. 2000;21:115–37.

25.

Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME. Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int. 2002;13:874–81.PubMed

26.

Jee WS, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact. 2001;1:193–207.PubMed

27.

Turner AS. Animal models of osteoporosis — necessity and limitations. Eur Cell Mater. 2001;1:66–81.PubMed

28.

Duarte PM, Cesar Neto JB, Goncalves PF, Sallum EA, Nociti FH. Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent. 2003;12:340–6.PubMed

29.

Duarte PM, Goncalves PF, Casati MZ, Sallum EA, Nociti Jr FH. Age-related and surgically induced estrogen deficiencies may differently affect bone around titanium implants in rats. J Periodontol. 2005;76:1496–501.PubMed

30.

Yamazaki M, Shirota T, Tokugawa Y, Motohashi M, Ohno K, Michi K, et al. Bone reactions to titanium screw implants in ovariectomized animals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:411–8.PubMed

31.

Lugero GG, de Falco CV, Guzzo ML, Konig Jr B, Jorgetti V. Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dent. 2000;9:303–9.PubMed

32.

Mori H, Manabe M, Kurachi Y, Nagumo M. Osseointegration of dental implants in rabbit bone with low mineral density. J Oral Maxillofac Surg. 1997;55:351–61.PubMed

33.

Fini M, Giavaresi G, Aldini NN, Torricelli P, Morrone G, Guzzardella GA, et al. The effect of osteopenia on the osteointegration of different biomaterials: histomorphometric study in rats. J Mater Sci Mater Med. 2000;11:579–85.PubMed

34.

Fini M, Giavaresi G, Greggi T, Martini L, Aldini NN, Parisini P, et al. Biological assessment of the bone-screw interface after insertion of uncoated and hydroxyapatite-coated pedicular screws in the osteopenic sheep. J Biomed Mater Res A. 2003;66:176–83.PubMed

35.

Borsari V, Fini M, Giavaresi G, Rimondini L, Consolo U, Chiusoli L, et al. Osteointegration of titanium and hydroxyapatite rough surfaces in healthy and compromised cortical and trabecular bone: in vivo comparative study on young, aged, and estrogen-deficient sheep. J Orthop Res. 2007;25:1250–60.PubMed

36.

Cho P, Schneider GB, Krizan K, Keller JC. Examination of the bone-implant interface in experimentally induced osteoporotic bone. Implant Dent. 2004;13:79–87.PubMed

37.

Vidigal Jr GM, Groisman M, Gregorio LH, Soares GA. Osseointegration of titanium alloy and HA-coated implants in healthy and ovariectomized animals: a histomorphometric study. Clin Oral Implants Res. 2009;20:1272–7.PubMed

38.

Keller JC, Stewart M, Roehm M, Schneider GB. Osteoporosis-like bone conditions affect osseointegration of implants. Int J Oral Maxillofac Implants. 2004;19:687–94.PubMed

39.

Frost HM. A 2003 update of bone physiology and Wolff's Law for clinicians. Angle Orthod. 2004;74:3–15.PubMed

40.

Weber K, Kaschig C, Erben RG. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats. Bone. 2004;35:704–10.PubMed

41.

Jager M, Begg MJ, Ready J, Bittersohl B, Millis M, Krauspe R, et al. Primary total hip replacement in childhood, adolescence and young patients: quality and outcome of clinical studies. Technol Health Care. 2008;16:195–214.PubMed

42.

Hayashi K, Uenoyama K, Mashima T, Sugioka Y. Remodeling of bone around hydroxyapatite and titanium in experimental osteoporosis. Biomaterials. 1994;15:11–6.PubMed

43.

Hara T, Hayashi K, Nakashima Y, Kanemaru T, Iwamoto Y. The effect of hydroxyapatite coating on the bonding of bone to titanium implants in the femora of ovariectomized rats. J Bone Joint Surg. 1999;81-B:705–9.

44.

Alghamdi HS, Bosco R, van den Beucken JJ, Walboomers XF, Jansen JA. Osteogenicity of titanium implants coated with calcium phosphate or collagen type-I in osteoporotic rats. Biomaterials. 2013;34:3747–57.PubMed

45.

Yan S, Cai X, Yan W, Dai X, Wu H. Continuous wave ultrasound enhances vancomycin release and antimicrobial efficacy of antibiotic-loaded acrylic bone cement in vitro and in vivo. J Biomed Mater Res B Appl Biomater. 2007;82:57–64.PubMed

46.

Alghamdi HS, Junker R, Bronkhorst EM, Jansen JA. Bone regeneration related to calcium phosphate-coated implants in osteoporotic animal models: a meta-analysis. Tissue Eng Part B Rev. 2012;18:383–95.PubMed

47.

Ruffoni D, Wirth AJ, Steiner JA, Parkinson IH, Muller R, van Lenthe GH. The different contributions of cortical and trabecular bone to implant anchorage in a human vertebra. Bone. 2012;50:733–8.PubMed

48.

Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: an exploratory case–control study. J Periodontol. 2000;71:625–31.PubMed

49.

Klemetti E, Vainio P, Lassila V, Alhava E. Cortical bone mineral density in the mandible and osteoporosis status in postmenopausal women. Scand J Dent Res. 1993;101:219–23.PubMed

50.

Taguchi A, Tanimoto K, Suei Y, Ohama K, Wada T. Relationship between the mandibular and lumbar vertebral bone mineral density at different postmenopausal stages. Dentomaxillofac Radiol. 1996;25:130–5.PubMed

51.•

Aro HT, Alm JJ, Moritz N, Makinen TJ, Lankinen P. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients. Acta Orthop. 2012;83:107–14. This paper describes the challenges associated with low bone mass on the success of orthopedic implants. In addition to bone mass, structural changes to the host femur and aging are also implicated as risk factors for stem migration. PubMed

52.

Alm JJ, Makinen TJ, Lankinen P, Moritz N, Vahlberg T, Aro HT. Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty. Acta Orthop. 2009;80:531–7.PubMed

53.

Moritz N, Alm JJ, Lankinen P, Makinen TJ, Mattila K, Aro HT. Quality of intertrochanteric cancellous bone as predictor of femoral stem RSA migration in cementless total hip arthroplasty. J Biomech. 2011;44:221–7.PubMed

54.

Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone. 1993;14:231–42.PubMed

55.

Sah AP, Thornhill TS, Leboff MS, Glowacki J. Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int. 2007;18:1119–26.PubMedCentralPubMed

56.

Nixon M, Taylor G, Sheldon P, Iqbal SJ, Harper W. Does bone quality predict loosening of cemented total hip replacements? J Bone Joint Surg Br. 2007;89:1303–8.PubMed

57.

McAuley JP, Moore KD, Culpepper WJ, Engh CA. Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am. 1998;80:1648–55.PubMed

58.

Nishino T, Mishima H, Miyakawa S, Kawamura H, Ochiai N. Midterm results of the Synergy cementless tapered stem: stress shielding and bone quality. J Orthop Sci. 2008;13:498–503.PubMed

59.

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2007;65:369–76.

60.

Zahrowski JJ. Comment on the American Association of Oral and Maxillofacial Surgeons Statement on Bisphosphonates. J Oral Maxillofac Surg. 2007;65:1440–1.PubMed

61.

Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008;66:223–30.PubMed

62.

Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol. 2010;81:479–84.PubMed

63.

Bilezikian JP. Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med. 2006;355:2278–81.PubMed

64.

Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761–71.PubMed

65.

Prieto-Alhambra D, Javaid MK, Judge A, Murray D, Carr A, Cooper C, et al. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ. 2011;343:d7222.PubMedCentralPubMed

66.

Curtin BM, Fehring TK. Bisphosphonate fractures as a cause of painful total hip arthroplasty. Orthopedics. 2011;34:e939–44.PubMed

67.

Cross MB, Nam D, van der Meulen MC, Bostrom MP. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. J Bone Joint Surg Br. 2012;94:994–7.PubMed

68.•

Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone. 2010;46:946–51. This review provides a nice summary of the use of bisphosphonate and how they affect failure rates of orthopedic implants. PubMed

69.

Russell RG, Croucher PI, Rogers MJ. Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int. 1999;9 Suppl 2:S66–80.PubMed

70.

Licata AA. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother. 2005;39:668–77.PubMed

71.

Kurth AH, Eberhardt C, Muller S, Steinacker M, Schwarz M, Bauss F. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone. 2005;37:204–10.PubMed

72.

Chen B, Li Y, Yang X, Xu H, Xie D. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Osteoporos Int. 2013;24:2115–21.PubMed

73.

Skripitz R, Johansson HR, Ulrich SD, Werner A, Aspenberg P. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci. 2009;14:138–43.PubMed

74.

Chen BL, Xie DH, Zheng ZM, Lu W, Ning CY, Li YQ, et al. Comparison of the effects of alendronate sodium and calcitonin on bone-prosthesis osseointegration in osteoporotic rats. Osteoporos Int. 2011;22:265–70.PubMed

75.

Viera-Negron YE, Ruan WH, Winger JN, Hou X, Sharawy MM, Borke JL. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol. 2008;34:76–82.PubMed

76.

Qi M, Hu J, Li J, Li J, Dong W, Feng X, et al. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone. 2012;50:119–27.PubMed

77.

Tsetsenekou E, Papadopoulos T, Kalyvas D, Papaioannou N, Tangl S, Watzek G. The influence of alendronate on osseointegration of nanotreated dental implants in New Zealand rabbits. Clin Oral Implants Res. 2012;23:659–66.PubMed

78.

Yildiz A, Esen E, Kurkcu M, Damlar I, Daglioglu K, Akova T. Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model. J Oral Maxillofac Surg. 2010;68:515–23.PubMed

79.•

Gao Y, Zou S, Liu X, Bao C, Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009;30:1790–6. A head-to-head comparison of various bisphosphonates. In addition to the implant fixation endpoints, the authors also report data on the release kinetics and the peri-implant trabecular architecture. PubMed

80.

Peter B, Gauthier O, Laib S, Bujoli B, Guicheux J, Janvier P, et al. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. J Biomed Mater Res A. 2006;76:133–43.PubMed

81.

Stadelmann VA, Gauthier O, Terrier A, Bouler JM, Pioletti DP. Implants delivering bisphosphonate locally increase peri-prosthetic bone density in an osteoporotic sheep model. A pilot study Eur Cell Mater. 2008;16:10–6.

82.

Reszka AA, Rodan GA. Bisphosphonate mechanism of action. Curr Rheumatol Rep. 2003;5:65–74.PubMed

83.

Arabmotlagh M, Rittmeister M, Hennigs T. Alendronate prevents femoral peri-prosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res. 2006;24:1336–41.PubMed

84.

Tapaninen TS, Venesmaa PK, Jurvelin JS, Miettinen HJ, Kroger HP. Alendronate reduces peri-prosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients. Scand J Surg. 2010;99:32–7.PubMed

85.

Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M. Changes of femoral peri-prosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty. J Orthop Res. 2009;27:183–8.PubMed

86.

Venesmaa PK, Kroger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhav EM. Alendronate reduces peri-prosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res. 2001;16:2126–31.PubMed

87.

Yamaguchi K, Masuhara K, Yamasaki S, Nakai T, Fuji T. Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty. Bone. 2003;33:144–9.PubMed

88.

Wilkinson JM, Stockley I, Peel NF, Hamer AJ, Elson RA, Barrington NA, et al. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial. J Bone Miner Res. 2001;16:556–64.PubMed

89.

Skoldenberg OG, Salemyr MO, Boden HS, Ahl TE, Adolphson PY. The effect of weekly risedronate on peri-prosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2011;93:1857–64.PubMed

90.

Yamasaki S, Masuhara K, Yamaguchi K, Nakai T, Fuji T, Seino Y. Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty. Osteoporos Int. 2007;18:1009–15.PubMed

91.

Trevisan C, Ortolani S, Romano P, Isaia G, Agnese L, Dallari D, et al. Decreased peri-prosthetic bone loss in patients treated with clodronate: a 1-year randomized controlled study. Calcif Tissue Int. 2010;86:436–46.PubMed

92.

Fokter SK, Komadina R, Repse-Fokter A, Yerby SA, Kocijancic A, Marc J. Etidronate does not suppress peri-prosthetic bone loss following cemented hip arthroplasty. Int Orthop. 2005;29:362–7.PubMedCentralPubMed

93.

Muratore M, Quarta E, Quarta L, Calcagnile F, Grimaldi A, Orgiani MA, et al. Ibandronate and cementless total hip arthroplasty: densitometric measurement of peri-prosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab. 2012;9:50–5.PubMedCentralPubMed

94.

Scott DF, Woltz JN, Smith RR. Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial. J Arthroplasty. 2013;28:671–5.PubMed

95.

Friedl G, Radl R, Stihsen C, Rehak P, Aigner R, Windhager R. The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial. J Bone Joint Surg Am. 2009;91:274–81.PubMed

96.

Khosla S. Mini-review: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050–5.PubMed

97.

McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354:821–31.PubMed

98.

Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwinski E, et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res. 2012;27:694–701.PubMedCentralPubMed

99.

Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res. 2002;20:169–73.PubMed

100.

Yang SY, Mayton L, Wu B, Goater JJ, Schwarz EM, Wooley PH. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum. 2002;46:2514–23.PubMed

101.

Ulrich-Vinther M, Carmody EE, Goater JJ, Balle S, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am. 2002;84-A:1405–12.PubMed

102.

von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A. 2005;75:288–94.

103.

Ren W, Wu B, Peng X, Hua J, Hao HN, Wooley PH. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(−/−) mice. J Orthop Res. 2006;24:1575–86.PubMed

104.

Zhang T, Yu H, Gong W, Zhang L, Jia T, Wooley PH, et al. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials. 2009;30:6102–8.PubMedCentralPubMed

105.

Zhang L, Jia TH, Chong AC, Bai L, Yu H, Gong W, et al. Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. Gene Ther. 2010;17:1262–9.PubMedCentralPubMed

106.

Wang H, Jia TH, Zacharias N, Gong W, Du HX, Wooley PH, et al. Combination gene therapy targeting on interleukin-1beta and RANKL for wear debris-induced aseptic loosening. Gene Ther. 2012.

107.

Tsutsumi R, Hock C, Bechtold CD, Proulx ST, Bukata SV, Ito H, et al. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res. 2008;26:1340–6.PubMedCentralPubMed

108.

Mosekilde L, Torring O, Rejnmark L. Emerging anabolic treatments in osteoporosis. Curr Drug Saf. 2011;6:62–74.PubMed

109.

Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab. 2012;97:311–25.PubMed

110.

Gabet Y, Muller R, Levy J, Dimarchi R, Chorev M, Bab I, et al. Parathyroid hormone 1–34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone. 2006;39:276–82.PubMed

111.

Ohkawa Y, Tokunaga K, Endo N. Intermittent administration of human parathyroid hormone (1–34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora. J Orthop Sci. 2008;13:533–42.PubMed

112.

Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350:459–68.PubMed

113.

Li Y, Li X, Song G, Chen K, Yin G, Hu J. Effects of strontium ranelate on osseointegration of titanium implant in osteoporotic rats. Clin Oral Implants Res. 2012;23:1038–44.PubMed

114.

Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J. Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res. 2010;28:578–82.PubMed

115.

Hayashi K, Fotovati A, Abu AS, Nakamura Y, Inagaki M, Naito M. Effect of a prostaglandin EP4 receptor agonist on early fixation of hydroxyapatite/titanium composite- and titanium-coated rough-surfaced implants in ovariectomized rats. J Biomed Mater Res A. 2010;92:1202–9.PubMed

116.

Zhou C, Li Y, Wang X, Shui X, Hu J. 1,25Dihydroxy vitamin D(3) improves titanium implant osseointegration in osteoporotic rats. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:S174–8.PubMed

117.

Du Z, Chen J, Yan F, Xiao Y. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Implants Res. 2009;20:145–50.PubMed

118.

Oteo-Alvaro A, Matas JA, Alonso-Farto JC. Teriparatide (rh [1–34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening. Orthopedics. 2011;34:e574–7.PubMed

119.

Virdi AS, Liu M, Sena K, Maletich J, McNulty M, Ke HZ, et al. Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. J Bone Joint Surg Am. 2012;94:1670–80.PubMed

120.

Agholme F, Isaksson H, Kuhstoss S, Aspenberg P. The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone. 2011;48:988–96.PubMed

121.•

Liu S, Virdi AS, Sena K, Sumner DR. Sclerostin antibody prevents particle-induced implant loosening by stimulating bone formation and inhibiting bone resorption in a rat model. Arthritis Rheum. 2012;64:4012–20. A study that adds particle-induced peri-implant osteolysis as another challenge to the use of biological treatments to augment implant fixation. PubMed

122.

Gao Y, Luo E, Hu J, Xue J, Zhu S, Li J. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone. 2009;44:225–32.PubMed

123.

Li Y, Gao Y, Song G, Liu X, Hu J. Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:700–5.PubMed

124.

Li YF, Li XD, Bao CY, Chen QM, Zhang H, Hu J. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1–34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int. 2013;24:1063–71.PubMed

125.

Gao Y, Zhu S, Luo E, Li J, Feng G, Hu J. Basic fibroblast growth factor suspended in Matrigel improves titanium implant fixation in ovariectomized rats. J Control Release. 2009;139:15–21.PubMed

126.

Maimoun L, Brennan TC, Badoud I, Dubois-Ferriere V, Rizzoli R, Ammann P. Strontium ranelate improves implant osseointegration. Bone. 2010;46:1436–41.PubMed

127.

Okamoto Y, Tateishi H, Kinoshita K, Tsuchiya S, Hibi H, Ueda M. An experimental study of bone healing around the titanium screw implants in ovariectomized rats: enhancement of bone healing by bone marrow stromal cells transplantation. Implant Dent. 2011;20:236–45.PubMed

Title: Pharmacologic Augmentation of Implant Fixation in Osteopenic Bone
Authors: R. D. Ross
J. L. Hamilton
B. M. Wilson
D. R. Sumner
A. S. Virdi
Publication date: 01-03-2014
Publisher: Springer US
Published in: Current Osteoporosis Reports / Issue 1/2014
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI: https://doi.org/10.1007/s11914-013-0182-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pharmacologic Augmentation of Implant Fixation in Osteopenic Bone

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Biomaterial Scaffolds for Treating Osteoporotic Bone

Osteoblast-Chondrocyte Interactions in Osteoarthritis

Vitamin D Deficiency and its Role in Muscle-Bone Interactions in the Elderly

Bone Metabolism in Anorexia Nervosa

Review: Epidemiology and Pathophysiology of Atypical Femur Fractures

Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib